Monday, April 16, 2018 9:06:14 AM
ALT certainly has great potential in the long run with a catalyst within months (early 3rd quarter) and according to the CEO, funds up to 2019 suggesting but not guaranteeing no near term raise. The company was local for me until it moved to Gaithersburg MD which is a biotech and high tech hub and a good place for them to be. From what I read in local papers it is a very legitimate and well respected company, something not always found among such developing companies.
I re-entered for short swing (not looking currently to be long in ALT mainly due to the volatility of the overall market) because I had noted a recent pattern of the stock being driven down early and then bouncing back to opening price and higher and then dropping back. Was looking to catch the top of the bounce to sell. However, for whatever reason on the last 2 trading days there developed an unusually tiny spread with high volume but no volatility. I don't believe folks are entering these bids/asks out to the thousandth place; rather, the Market Makers are doing this for whatever reason. I suppose you realize that MMs bids and asks are not 1:1 to what traders offer. They can be higher or lower although the trader's actual bid or ask is the price recorded for the traders's shares. So if your bid is .82 the MM representing you could be paying .8237 per share to get you your wanted shares for which you will pay .82. You may already know this, but some folks don't
Good luck with this trade.
ALT
Recent ALT News
- Altimmune to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- Altimmune to Participate at Two Upcoming Conferences • GlobeNewswire Inc. • 05/01/2024 11:30:00 AM
- Altimmune Statement on the Passing of Dr. Stephen Harrison • GlobeNewswire Inc. • 04/25/2024 09:24:52 PM
- Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/27/2024 11:00:00 AM
- U.S. Stock Index Futures Point to a Rebound, Oil See Declines in Early Trading • IH Market News • 03/27/2024 10:57:08 AM
- Altimmune to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 27, 2024 • GlobeNewswire Inc. • 03/20/2024 11:30:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 05:04:25 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 11:37:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:02:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:01:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:00:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 11:03:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 11:02:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 11:01:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 11:01:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 11:00:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 11:32:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 11:32:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 11:31:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 11:30:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 11:30:13 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/26/2024 04:49:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 11:00:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 11:00:20 PM
- Altimmune Announces Presentation of Pemvidutide Clinical Data at Upcoming NASH-TAG Conference on January 6, 2024 • GlobeNewswire Inc. • 01/02/2024 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM